Enhancement of cardiac myoblast responses onto electrospun PLCL fibrous matrices coated with polydopamine for gelatin immobilization

被引:0
作者
Young Min Shin
Hansoo Park
Heungsoo Shin
机构
[1] Hanyang University,Department of Bioengineering
[2] Chung-ang University,Department of Biomedical engineering
[3] Hanyang University,Institute for Bioengineering and Biopharmaceutical Research
[4] Hanyang University,Institute of Aging Society
来源
Macromolecular Research | 2011年 / 19卷
关键词
surface modification; polydopamine; electrospinning; gelatin;
D O I
暂无
中图分类号
学科分类号
摘要
A variety of surface modification techniques have been proposed to improve the cell-biomaterial interactions. On the other hand, these processes may cleave long-chained polymers, and compromise their mechanical properties. In this study, dopamine was used as a bridge molecule to immobilize gelatin on the poly(L-lactide-co-ɛ-caprolactone) (PLCL) fibrous matrices, which may then be used as a cell delivery carrier. The PLCL fibrous matrices coated with polydopamine by dipping (D-PLCL) can subsequently immobilize gelatin (GD-PLCL). The D-PLCL matrices showed minimal changes in the mechanical properties with a tensile strain of 251.0±33.4% and 247.8±32.1% before and after the coating process, respectively. The cellular activities on the fibrous matrices increased in the order of PLCL<G-PLCL<D-PLCL<GD-PLCL; the H9c2 myoblasts on the GD-PLCL matrices showed approximately two-times higher adhesion and spreading than those on the PLCL matrices, and the proliferation was significantly greater on the GD-PLCL matrices than on the other matrices. Therefore, polydopamine can effectively immobilize the bioactive functional groups on the surface of electrospun fibrous matrices for the development of a tissue specific cell delivery carrier.
引用
收藏
页码:835 / 842
页数:7
相关论文
共 191 条
[1]  
Eschenhagen T.(2005)undefined Circ. Res. 97 1220-undefined
[2]  
Zimmermann W. H.(2001)undefined Hypertension 38 1413-undefined
[3]  
Hagege A. A.(2007)undefined Circ. Res. 100 263-undefined
[4]  
Vilquin J. T.(2006)undefined Surgery 140 100-undefined
[5]  
Bruneval P.(2009)undefined Eur. J. Heart Fail. 11 147-undefined
[6]  
Menasche P.(2009)undefined J. Cardiovasc. Med. (Hagerstown) 10 624-undefined
[7]  
Caspi O.(2005)undefined Proc. Natl. Acad. Sci. U.S.A. 102 8692-undefined
[8]  
Lesman A.(2004)undefined Curr. Opin. Biotechnol. 15 430-undefined
[9]  
Basevitch Y.(2002)undefined Circulation 106 I151-undefined
[10]  
Gepstein A.(2000)undefined Circulation 102 III56-undefined